Venture Capital Archives - Page 30 of 99

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

THIS WEEK'S STORIES

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

INBRAIN Neuroelectronics Secures €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene Brain-Computer Interfaces

May 6, 2025

MassBio Warns of Looming Crisis in U.S. Biotech Sector as Federal Cuts and Trade Barriers Mount

May 6, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies

Jaanuu Acquired by VentureOn Management in Strategic Asset Sale

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

GeneDx Completes Acquisition of Fabric Genomics to Expand Global Genomic Medicine Capabilities

Most Read

K Health’s AI Physician Mode Joins Mayo Clinic Platform to Boost Primary Care Efficiency

FDA Approves GE HealthCare’s Optison for Pediatric Use, Expanding Access to Enhanced Heart Imaging

Vicarious Surgical Partners with UMass Memorial Medical Center to Advance Robotic Surgery Integration

Freespira Gains FDA Clearance for At-Home Anxiety and PTSD Treatment for Adolescents

EDITOR PICKS

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

THIS WEEK'S STORIES

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

INBRAIN Neuroelectronics Secures €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene Brain-Computer Interfaces

MassBio Warns of Looming Crisis in U.S. Biotech Sector as Federal Cuts and Trade Barriers Mount

POPULAR CATEGORY

ABOUT US

FOLLOW US